首页> 外文OA文献 >Venous thromboembolism in patients with reduced estimated GFR: a population-based perspective
【2h】

Venous thromboembolism in patients with reduced estimated GFR: a population-based perspective

机译:估计GFR降低的患者的静脉血栓栓塞:基于人群的观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: An increased frequency of venous thromboembolism (VTE) has been shown in patients with decreased kidney function measured by decreased estimated glomerular filtration rate (eGFR). However, present practices with respect to VTE prevention and management in patients with decreased eGFR in general population settings are uncertain.STUDY DESIGN: Observational study.SETTING and PARTICIPANTS: Community investigation of 1,509 metropolitan Worcester, MA, residents with a validated VTE in 1999, 2001, and 2003 with further follow-up for up to 3 years.PREDICTOR: Patients with VTE classified further according to eGFR on presentation: /=90 mL/min/1.73 m(2) (reference group).OUTCOMES: Recurrent VTE, major bleeding episodes, and all-cause mortality.MEASUREMENTS: Demographic and clinical characteristics, treatment practices, and study outcomes were extracted from patients\u27 hospital and outpatient medical records; eGFR was estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.RESULTS: Patients with VTE with eGFR /min/1.73 m(2) were at increased risk of recurrent VTE (HR, 1.83; 95% CI, 1.03-3.25), major bleeding episodes (HR, 2.30; 95% CI, 1.28-4.16), and all-cause mortality (HR, 1.70; 95% CI, 1.12-2.57) during a 3-year follow-up. Patients with decreased eGFR also presented with more comorbid conditions and were less likely to be discharged on any form of anticoagulant therapy (72.6%, 81.0%, 82.1%, and 87.3% for eGFR /=90 mL/min/1.73 m(2), respectively; P \u3c 0.001).LIMITATIONS: Decreased eGFR status is presumed based on creatinine values on clinical presentation. The impact of drug dosage, timing, type of anticoagulant therapy, and medication adherence on study outcomes could not be evaluated.CONCLUSIONS: Severe decreases in eGFR are associated with increased risk of long-term recurrent VTE, bleeding, and total mortality in patients with VTE. A greater frequency of serious comorbid conditions, difficulties implementing available management strategies, and suboptimal VTE prophylaxis during hospital admissions likely contributed to our findings. All rights reserved.
机译:背景:通过降低估计的肾小球滤过率(eGFR)来衡量肾功能下降的患者,静脉血栓栓塞(VTE)的频率增加。然而,目前在一般人群中eGFR降低的患者在VTE预防和管理方面的实践尚不确定。研究设计:观察性研究背景和参与者:1999年对马萨诸塞州伍斯特市1,509名经VTE验证的居民进行社区调查, 2001年和2003年,并进行了长达3年的随访。预测:VTE患者根据呈报的eGFR进一步分类:/ = 90 mL / min / 1.73 m(2)(参考组)。结果:复发性VTE,方法:从患者的医院和门诊病历中提取人口统计学和临床​​特征,治疗方法和研究结果。使用慢性肾脏病流行病学协作(CKD-EPI)方程估算eGFR。结果:eGFR /min/1.73 m(2)的VTE患者复发VTE的风险增加(HR,1.83; 95%CI,1.03- 3.25),3年随访期间的主要出血发作(HR,2.30; 95%CI,1.28-4.16)和全因死亡率(HR,1.70; 95%CI,1.12-2.57)。 eGFR降低的患者也出现更多的合并症,并且接受任何形式的抗凝治疗的可能性均较小(eGFR / = 90 mL / min / 1.73 m(22.6%,81.0%,82.1%和87.3%) ,分别; P \ u3c 0.001)。局限性:临床表现基于肌酐值推测eGFR状态降低。结论:eGFR的严重降低与长期复发VTE,出血和总死亡率的风险增加有关,因此无法评估药物剂量,时机,抗凝治疗的类型以及药物依从性对研究结果的影响。 VTE。严重合并症的发生频率较高,入院期间难以实施有效的管理策略以及预防性VTE不足可能是导致我们发现的原因。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号